At a glance
Stallergenes Greer is a fully integrated global biopharmaceutical company specialising in the research, diagnosis and treatment of allergies through the development and commercialisation of allergen immunotherapy (AIT) products and services.
The Group’s extensive product portfolio, available in multiple formulations (subcutaneous, sublingual drops and tablets), offers patients innovative solutions to improve quality of life for people with allergies.
A world leader in allergen immunotherapy, Stallergenes Greer has an extensive global footprint and the largest allergen and finished AIT product manufacturing capacity globally.
1,102
employees worldwide
19
countries with a direct presence
41
countries with a distribution network